Market Tracker

09/04 12:33pm ET

NxStage Medical Inc (NASDAQ:NXTM)

16.60
Delayed Data
As of 12:15pm ET
 +0.15 / +0.91%
Today’s Change
11.50
Today|||52-Week Range
19.63
-7.42%
Year-to-Date

Today’s Trading

Previous close16.45
Today’s open16.35
Day’s range16.28 - 16.70
Volume82,531
Average volume (3 months)598,659
Market cap$1.0B
Dividend yield--
Data as of 12:15pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-25.81%
Earnings growth (this year)+20.51%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.45%
P/E ratioNM
Price/Sales3.67
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...+0.11+0.91%
EXELExelixis Inc+0.07+1.26%
FGENFibroGen Inc+0.36+1.59%
AMRIAlbany Molecular Res...-0.11-0.55%
Data as of 12:32pm ET, 09/04/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$301.5M
Annual profit (last year)-$23.9M
Net profit margin-7.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Jeffrey H. Burbank
President
Joseph E. Turk
Corporate headquarters
Lawrence, Massachusetts

Forecasts